ID   LA1-55n
AC   CVCL_2548
DR   BTO; BTO:0005860
DR   ECACC; 06041203
DR   Wikidata; Q54901883
RX   PubMed=10485488;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Doubling time: ~2 days (ECACC=06041203).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2549 ! LA1-5s
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=10485488;
RA   Glick R.D., Swendeman S.L., Coffey D.C., Rifkind R.A., Marks P.A.,
RA   Richon V.M., La Quaglia M.P.;
RT   "Hybrid polar histone deacetylase inhibitor induces apoptosis and
RT   CD95/CD95 ligand expression in human neuroblastoma.";
RL   Cancer Res. 59:4392-4399(1999).
//
RX   PubMed=15720811; DOI=10.1593/neo.04310;
RA   Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.-F.,
RA   Biedler J.L., Cheung N.-K.V., Ross R.A.;
RT   "Characteristics of stem cells from human neuroblastoma cell lines and
RT   in tumors.";
RL   Neoplasia 6:838-845(2004).
//
RX   PubMed=26342562; DOI=10.1016/j.scr.2015.08.008;
RA   Ross R.A., Walton J.D., Han D., Guo H.-F., Cheung N.-K.V.;
RT   "A distinct gene expression signature characterizes human
RT   neuroblastoma cancer stem cells.";
RL   Stem Cell Res. 15:419-426(2015).
//